NasdaqGS - Nasdaq Real Time Price USD
Acumen Pharmaceuticals, Inc. (ABOS)
0.9801
-0.0199
(-1.99%)
At close: May 9 at 4:00:00 PM EDT
0.9801
0.00
(0.00%)
After hours: May 9 at 4:05:09 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -0.55 | -0.53 | -2.32 | -1.88 |
| Low Estimate | -0.62 | -0.64 | -2.6 | -2.09 |
| High Estimate | -0.45 | -0.48 | -2.01 | -1.75 |
| Year Ago EPS | -0.25 | -0.34 | -1.71 | -2.32 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 4 | 3 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.23 | -0.25 | -0.3 | -0.37 |
| EPS Actual | -0.25 | -0.34 | -0.5 | -0.62 |
| Difference | -0.02 | -0.09 | -0.2 | -0.25 |
| Surprise % | -6.58% | -35.33% | -68.46% | -69.48% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.55 | -0.53 | -2.32 | -1.88 |
| 7 Days Ago | -0.51 | -0.48 | -2.23 | -1.59 |
| 30 Days Ago | 0 | 0 | -1.53 | -1.59 |
| 60 Days Ago | 0 | 0 | -1.53 | -1.59 |
| 90 Days Ago | 0 | 0 | -1.53 | -1.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | 1 | 1 | 3 | 2 |
| Down Last 30 Days | 1 | 1 | 3 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ABOS | -118.40% | -56.84% | -35.66% | 18.92% |
| S&P 500 | 13.06% | 3.09% | 8.02% | 13.74% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 3/28/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/28/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/13/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/3/2024 |
| Maintains | UBS: Buy to Buy | 8/15/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/14/2024 |
Related Tickers
ACRV Acrivon Therapeutics, Inc.
1.1600
-1.69%
KYTX Kyverna Therapeutics, Inc.
2.1100
-0.94%
CLYM Climb Bio Inc
1.1900
0.00%
ARTV Artiva Biotherapeutics, Inc.
2.0800
-4.59%
ITOS iTeos Therapeutics, Inc.
6.67
-0.52%
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
ACXP Acurx Pharmaceuticals, Inc.
0.3600
-4.79%
INZY Inozyme Pharma, Inc.
1.1500
-7.26%
TNGX Tango Therapeutics, Inc.
1.1400
+3.64%
ELDN Eledon Pharmaceuticals, Inc.
2.8900
-8.83%